Inhibrx Biosciences, Inc.
INBX
$82.96
$0.710.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.03% | -17.76% | -- | -45.09% | -- |
| Total Receivables | -25.73% | -30.28% | -29.61% | -46.02% | -- |
| Inventory | -26.28% | -49.71% | -77.26% | -79.79% | -- |
| Prepaid Expenses | -30.26% | -63.98% | -33.06% | -26.22% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.88% | -27.86% | 32.15% | 9.51% | -- |
| Total Current Assets | -22.19% | -19.87% | 1,475.03% | -45.69% | -- |
|
|
|||||
| Total Current Assets | -22.19% | -19.87% | 1,475.03% | -45.69% | -- |
| Net Property, Plant & Equipment | 22.68% | 17.98% | 31.70% | 44.47% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -14.51% | 0.95% | 48.34% | 115.90% | -- |
| Total Assets | -20.26% | -17.92% | 759.75% | -41.29% | -- |
|
|
|||||
| Total Accounts Payable | -7.04% | -4.70% | 0.22% | -55.90% | -- |
| Total Accrued Expenses | -26.43% | 3.70% | 28.29% | 18.34% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.45% | -0.09% | -6.80% | -22.69% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -18.40% | -0.29% | 13.55% | -27.67% | -- |
|
|
|||||
| Total Current Liabilities | -18.40% | -0.29% | 13.55% | -27.67% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 952.41% | 481.35% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 218.95% | 267.61% | 280.07% | -82.15% | -- |
|
|
|||||
| Common Stock & APIC | 5.68% | 5.51% | 2,364.49% | -63.53% | -- |
| Retained Earnings | -266.16% | -1,136.53% | -- | 82.71% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -79.36% | -68.75% | 976.91% | 207.07% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -79.36% | -68.75% | 976.91% | 207.07% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -79.36% | -68.75% | 976.91% | 207.07% | -- |
|
|
|||||